Bio-Rad Laboratories, Inc.
BIO· NYSE
BIOBio-Rad Laboratories, Inc.
Filed Mar 18, 2013 · 10-K · 77 days after period end · 0000012208-13-000007
| Metric | Q4 2012 | Q4 2011 | Q4 2010 | Q4 2009dderived from reported figures |
|---|---|---|---|---|
| Revenue | $573.80M | $550.20M | $533.70M | — |
| Net Income | $42.00M | $59.20M | $67.90M | — |
| EPS Diluted | $1.46 | $2.08 | $2.41 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Rad Laboratories, Inc. · CIK 12208 · Engraved from SEC EDGAR
ended Dec 31, 2012 · filed Mar 18, 2013 · 77 d after period end
